These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 23124277)
21. Interleukin-1 beta polymorphisms are associated with lymph node metastasis in Korean patients with papillary thyroid carcinoma. Ban JY; Kim MK; Park SW; Kwon KH Immunol Invest; 2012; 41(8):888-905. PubMed ID: 23215728 [TBL] [Abstract][Full Text] [Related]
22. Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry. Bychkov A; Saenko V; Nakashima M; Mitsutake N; Rogounovitch T; Nikitski A; Orim F; Yamashita S Thyroid; 2013 Jul; 23(7):817-28. PubMed ID: 23327367 [TBL] [Abstract][Full Text] [Related]
23. Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer. Çil E; Kumral A; Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Altuntaş Y; Uysal M Mol Biol Rep; 2014 May; 41(5):3091-7. PubMed ID: 24464184 [TBL] [Abstract][Full Text] [Related]
24. Polymorphisms of methylenetetrahydrofolate reductase and glutathione S-transferase are not associated with the risk of papillary thyroid cancer in Korean population. Kweon SS; Shin MH; Kim HN; Kim SH; Kang HC Mol Biol Rep; 2014 Jun; 41(6):3793-9. PubMed ID: 24535271 [TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphisms in TLR1, TLR2, TLR4, and TLR10 of Helicobacter pylori-associated gastritis: a prospective cross-sectional study in Thailand. Tongtawee T; Bartpho T; Kaewpitoon S; Kaewpitoon N; Dechsukhum C; Leeanansaksiri W; Loyd RA; Talabnin K; Matrakool L; Panpimanmas S Eur J Cancer Prev; 2018 Mar; 27(2):118-123. PubMed ID: 28368946 [TBL] [Abstract][Full Text] [Related]
26. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer. Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935 [TBL] [Abstract][Full Text] [Related]
27. Association of Toll-like receptor 10 polymorphisms with autoimmune thyroid disease in Korean children. Cho WK; Jang JP; Choi EJ; Jeon YJ; Jung IA; Kim SH; Jung MH; Kim TG; Suh BK Thyroid; 2015 Feb; 25(2):250-5. PubMed ID: 25295614 [TBL] [Abstract][Full Text] [Related]
28. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies. Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573 [TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma. Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298 [TBL] [Abstract][Full Text] [Related]
31. Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer. Eun YG; Lee YC; Kim SK; Chung JH; Kwon KH; Park IS Auris Nasus Larynx; 2015 Aug; 42(4):326-31. PubMed ID: 25824544 [TBL] [Abstract][Full Text] [Related]
32. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features. Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498 [TBL] [Abstract][Full Text] [Related]
33. Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population. Wang YX; Zhao L; Wang XY; Liu CM; Yu SG Endocrine; 2012 Jun; 41(3):526-31. PubMed ID: 22194161 [TBL] [Abstract][Full Text] [Related]
34. Epistatic effect of TLR-1, -6 and -10 polymorphisms on organic dust-mediated cytokine response. Smith LM; Weissenburger-Moser LA; Heires AJ; Bailey KL; Romberger DJ; LeVan TD Genes Immun; 2017 Mar; 18(2):67-74. PubMed ID: 28123183 [TBL] [Abstract][Full Text] [Related]
35. A missense polymorphism (rs11895564, Ala380Thr) of integrin alpha 6 is associated with the development and progression of papillary thyroid carcinoma in Korean population. Kim SK; Kim DK; Oh IH; Song JY; Kwon KH; Choe BK; Kim YH J Korean Surg Soc; 2011 Nov; 81(5):308-15. PubMed ID: 22148122 [TBL] [Abstract][Full Text] [Related]
36. 1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters. Dardano A; Falzoni S; Caraccio N; Polini A; Tognini S; Solini A; Berti P; Di Virgilio F; Monzani F J Clin Endocrinol Metab; 2009 Feb; 94(2):695-8. PubMed ID: 19017759 [TBL] [Abstract][Full Text] [Related]
37. OPN -443C>T genetic polymorphism and tumor OPN expression are associated with the risk and clinical features of papillary thyroid cancer in a Chinese cohort. Mu G; Wang H; Cai Z; Ji H Cell Physiol Biochem; 2013; 32(1):171-9. PubMed ID: 23867349 [TBL] [Abstract][Full Text] [Related]
38. MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression. Roncevic J; Djoric I; Selemetjev S; Jankovic J; Dencic TI; Bozic V; Cvejic D Pathology; 2019 Jan; 51(1):55-61. PubMed ID: 30497805 [TBL] [Abstract][Full Text] [Related]
39. Expression profile of Toll‑like receptors in human breast cancer. Shi S; Xu C; Fang X; Zhang Y; Li H; Wen W; Yang G Mol Med Rep; 2020 Feb; 21(2):786-794. PubMed ID: 31789409 [TBL] [Abstract][Full Text] [Related]